Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gufic Biosciences has informed the stock exchanges that its trading window will be closed from April 1, 2026 until 48 hours after the declaration of its audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2026. This is a mandatory compliance under SEBI's Insider Trading Regulations and applies to all designated persons and their immediate relatives. The board meeting date to approve the annual results has not yet been disclosed and will be communicated later. This signals that the company's FY26 annual earnings announcement is expected in the near future.
No direct impact on shareholders, but it indicates the FY26 audited results are imminent, which could be a key catalyst for the stock. The trading window closure is a routine regulatory requirement to prevent insider trading ahead of results.